The essential endoplasmic reticulum chaperone Rot1 is required for protein N- and O-glycosylation in yeast by Pasikowska, Monika et al.
1 
© The Author 2012. Published by Oxford University Press. All rights reserved. 
For Permissions, please e-mail: journals.permissions@oup.com 
The essential endoplasmic reticulum chaperone Rot1 is required for protein 
N- and O-glycosylation in yeast 
 
Monika Pasikowska1,2, Grazyna Palamarczyk2, and Ludwig Lehle1 
 
1Department of Cell Biology and Plant Biochemistry, University of Regensburg, 
Universitätsstrasse 31, D-93053 Regensburg, Germany 
2Laboratory of Fungal Glycobiology, Institute of Biochemistry and Biophysics, Polish 
Academy of Sciences, Pawinskiego 5a, 02106, Warsaw, Poland 
 
 
 
 
Corresponding Author: 
Dr. Ludwig Lehle 
Lehrstuhl für Zellbiologie und Pflanzenbiochemie 
Universität Regensburg 
Universitätsstrasse 31 
93053 Regensburg, Germany 
E-mail: ludwig.lehle@biologie.uni-regensburg.de 
 
 
 
 
 
 Glycobiology Advance Access published April 4, 2012
 at Instytut Biochem
ii i Biofizyki PA
N
 on A
pril 17, 2012
http://glycob.oxfordjournals.org/
D
ow
nloaded from
 
2 
Abstract 
Rot1 is an essential yeast protein originally shown to be implicated in such diverse processes 
such as β-1,6-glucan synthesis, actin cytoskeleton dynamics, or lysis of autophagic bodies. 
More recently also a role as a molecular chaperone has been discovered. Here we report that 
Rot1 interacts in a synthetic manner with Ost3, one of the nine subunits of the 
oligosaccharyltransferase complex, the key enzyme of N-glycosylation. Deletion of OST3 in 
the rot1-1 mutant causes a temperature sensitive phenotype as well as sensitivity towards 
compounds interfering with cell wall biogenesis such as Calcofluor White, caffeine, Congo 
Red and hygromycin B, whereas deletion of OST6, a functional homolog of OST3, has no 
effect. Oligosaccharyltransferase activity in vitro determined in membranes from rot1-1ost3∆ 
cells was found to be decreased to 45% compared to wild-type membranes, and model 
glycoproteins of N-glycosylation, like carboxypeptidase CPY, Gas1 or DPAP B, displayed an 
underglycosylation pattern. By affinity chromatography a physical interaction between Rot1 
and Ost3 was demonstrated. Moreover, Rot1 was found to be involved also in the O-
mannosylation process, as glycosylation of distinct glycoproteins of this type were affected as 
well. Altogether the data extend the role of Rot1 as a chaperone required to ensure proper 
glycosylation. 
 
Keywords:  ROT1/  N‐glycosylation/  O‐glycosylation/  oligosaccharyltransferase/  dolichol/ 
Saccharomyces cerevisiae 
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Introduction 
Protein-glycosylation of eukaryotic secretory and membrane-bound proteins, either in the 
form of N-glycosylation of asparagine residues or O-glycosylation of serine/threonine 
residues, is a fundamental and the most abundant protein modification in lower and higher 
eukaryotes, serving many intra- and extracellular functions (Helenius and Aebi 2004; Lehle et 
al. 2006; Ohtsubo and Marth 2006; Spiro 2002). 
The pivotal step of the N-glycosylation pathway is the en bloc transfer of the high mannose 
core oligosaccharide Glc3Man9GlcNAc2 from the lipid carrier dolicholphosphate to selected 
Asn-X-Ser/Thr sequences of the nascent polypeptide chain in the lumen of the endoplasmic 
reticulum (ER). The enzyme that catalyzes this process is a multisubunit membrane-complex, 
called oligosaccharyltransferase (OST) (Dempski and Imperiali 2002; Kelleher and Gilmore 
2006; Knauer and Lehle 1999; Schwarz and Aebi 2011; Yan and Lennarz 2005b). Purification 
of OST from yeast and genetic methods identified nine proteins as constituents of the 
complex. Five of them, Wbp1, Swp1, Stt3, Ost1 and Ost2, are essential for viability of the 
cell, whereas Ost3, Ost4, Ost5, and Ost6 are not essential, but are required for maximal OST 
activity. Apart from Stt3, identified as the catalytic subunit (Hese et al. 2009; Igura et al. 
2008; Lizak et al. 2011; Nasab et al. 2008), the specific function of the various other 
components is largely enigmatic. For the homologous Ost3 and Ost6 proteins it was shown 
that they are alternatively present in the OST together with the other subunits forming two 
distinct complexes (Schwarz et al. 2005; Spirig et al. 2005) differing in their substrate-specific 
activities at the level of individual glycosylation sites (Schulz and Aebi 2009). In addition, 
Ost3 and Ost6 exhibit oxidoreductase activity and bind specific polypeptides, both non-
covalently and via transient disulfide bonds. These subunits are thought to slow down early 
stages in protein folding, maintaining the nascent polypeptide chain in a glycosylation 
competent conformation (Schulz et al. 2009). There is also evidence that Ost3/Ost6 may 
specify the interaction with different translocation complexes (Yan and Lennarz 2005a). 
O-glycosylation in yeast is restricted exclusively to O-mannosylation of serine/threonine 
residues forming short linear oligomannose chains consisting of up to four mannose residues. 
O-mannosylation, first identified in yeast (Babczinski and Tanner 1973), was assumed for a 
long time to occur exclusively in fungi. However, it is now clear that this type of O-
glycosylation is conserved throughout the animal kingdom, including human (Lehle et al. 
2006; Lommel and Strahl 2009). Similarly as for N-glycosylation, but differently from other 
types of O-glycosylation, O-mannosylation is initiated in the ER, while the nascent 
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polypeptide is entering the lumen. The initial mannosyltranfer reaction is catalyzed by distinct 
complexes of the Dol-P-Man:protein O-mannosyltransferase (PMT) family, originally 
discovered in yeast (Gentzsch and Tanner 1996; Strahl-Bolsinger et al. 1993). It has also been 
shown that the N- and O-glycosylation machineries may compete for protein substrate (Ecker 
et al. 2003; Harty et al. 2001). 
ROT1, encoding an essential ER-localized membrane protein, was initially reported as a 
gene required for ß-1,6-glucan synthesis (Bickle et al. 1998; Machi et al. 2004). Mutations of 
ROT1 cause pleiotropic defects in cell wall synthesis, cytoskeleton dynamics, or in lysis of 
autophagic bodies (Takeuchi et al. 2006a; Takeuchi et al. 2006b). More recently it was 
demonstrated that Rot1 can function as a general chaperone exhibiting anti-aggregation 
activity in vitro, and in vivo the rot1-2 mutation caused an accelerated degradation of several 
proteins of the secretory pathway via ER-associated degradation (Takeuchi et al. 2008). 
Furthermore, ROT1 was shown to interact genetically with KAR2, encoding the yeast BiP, 
suggesting a cooperation of these two protein in the folding of nascent proteins (Takeuchi et 
al. 2006a). 
We previously observed that over-expression of ROT1 in sec59-1 cells, impaired in dolichol 
kinase, suppresses the temperature-sensitive phenotype of this mutant (Orlowski et al. 2007). 
As dolicholphosphate (Dol-P) is a key component in the formation of lipid-linked 
oligosaccharide, we asked, whether a direct role of Rot1 in protein glycosylation can be 
demonstrated. Here we show that N-glycosylation is impaired in vivo and in vitro in rot1-
1ost3∆ cells and that Rot1 physically interacts with the Ost3 subunit of OST. Quite 
unexpected, we observe that Rot1 is also required for O-mannosylation of proteins. 
 
Results 
Synthetic interaction of ROT1 and OST3 
OST3 and OST6 are two closely related, not essential subunits of two distinct OST isoforms, 
required for efficient N-glyosylation (Knauer and Lehle 1999; Schulz and Aebi 2009). As 
shown in Figure 1, deletion of OST6 displayed a growth phenotype, when stressed by agents 
known to interfere with cell wall biogenesis, such as Calcofluor White, caffeine, Congo Red 
or hygromycin B, whilst the ost3∆ strain proved more or less resistant at the concentrations 
used, similar to wild-type. Deletion of ROT1 is known to be lethal, but the rot1-1 mutant is 
viable and was hardly affected by aforementioned agents. However, growth of a rot1-1ost3∆ 
double mutant was abolished, while the rot1-1ost6∆ strain was not affected in a synthetic 
manner by these drugs and displayed only the phenotype of the ost6∆ single mutant. 
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Similarly, only rot1-1ost3∆ cells reveal a temperature-sensitive growth phenotype. Altogether 
the data suggest a synthetic interaction between Rot1 and Ost3 that does not apply to Rot1 in 
combination with Ost6. 
 
Rot1 is required for N-glycosylation 
The synthetic interaction between ROT1 and OST3 pointed to an involvement of ROT1 in N-
glycosylation. To investigate this in more detail, we examined the glycosylation status of 
several well characterized soluble and membrane-bound glycoproteins in single and double 
mutant strains. As depicted in Figure 2, Western blot analysis showed an underglycosylation 
of the soluble, vacuolar carboxypeptidase Y (CPY) only in rot1-1ost3∆ cells, indicated by the 
appearance of glycoforms migrating faster than mature CPY, lcking one, two or three N-
glycan chains. CPY containing four chains is the dominant species in wild-type cells. 
Similarly, also the vacuolar membrane glycoprotein dipeptidyl aminopeptidase B (DPAP B), 
the plasma membrane cell wall integrity sensor Mid2, or Gas1, a GPI-anchored β-1,3-
glucanosyltransferase involved in cell wall remodeling, displayed an underglycosylation 
pattern only in rot1-1ost3∆, but not in rot1-1ost6∆ and single deletion strains, respectively. 
The last two proteins carry also O-glycans. However, as it will be shown later (see Figure 4), 
the underglycosylation is due exclusively to the loss of N-linked glycans. 
 
Altered oligosaccharyltransferase and cis-prenyltransferase activity in the rot1-1ost3∆ 
mutant 
The phenotype of underglycosylation of proteins could be caused, amongst others, by a 
reduced activity of OST, or might be due to a reduced amount of the Dol-P precursor 
oligosaccharide. We therefore determined OST activity in vitro in microsomal membranes 
isolated from these strains. As shown in Figure 3A, OST activity reflected the 
underglycosylation observed in vivo. Whereas membranes from ost3∆ and ost6∆ single 
mutants displayed only a small decrease of activity, in the double mutant rot1-1ost3∆, but not 
in rot1-1ost6∆, it was severely reduced, indicative for the specific synthetic interaction 
between Rot1 and Ost3. We also determined the activity of cis-prenyltransferase, the first 
enzyme committed to the biosynthesis of the dolichol backbone, encoded by RER2 localized 
to the ER (Grabinska and Palamarczyk 2002). As can be seen in Figure 3B, also this activity 
was significantly reduced in a synthetic manner in rot1-1ost3∆ cells, indicating that disturbed 
Rot1 function in combination with impaired glycosylation due to deletion of OST3 may affect 
earlier steps of this pathway as well (for further discussion see below). 
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Rot1 affects O-mannosylation in vivo and in vitro 
The fact that there is a link between N- and O-glycosylation (Ecker et al. 2003) and both 
processes in yeast occur while the nascent, unfolded polypeptide is translocated into the ER 
lumen, prompted us to ask, whether Rot1 may also take an active role in O-mannosylation. As 
mentioned above, the initial mannosyltransfer reaction is catalyzed by heteromeric and 
homomeric, respectively, complexes of the Pmt1/Pmt2 and the Pmt4 subfamilies. The 
complexes differ in their target protein substrate specificity (Ecker et al. 2003; Gentzsch and 
Tanner 1996; Gentzsch and Tanner 1997; Lommel and Strahl 2009). As shown in Figure 4, 
Western blot analysis of endochitinase Cts1, an exclusively O-mannosylated protein, revealed 
that it migrated faster in rot1-1ost3∆, reflecting a defect in O-mannosyltransfer. Such a 
reduced O-mannosyltransferase activity could also be demonstrated in vitro in microsomal 
membranes (Figure 5). Pmt activity in rot1-1ost3∆ was decreased to 45% compared to wild-
type, rot1-1 or ost3∆ single mutant strains. 
Besides Cts1 further O-mannosylated proteins were investigated, like Ccw5, Gas1 and 
Mid2. In the case of Gas1 and Mid2 also N-glycosylation of the protein occurs (see above). In 
order to exclusively monitor O-mannosylation of these proteins, in case of Gas1, samples 
were treated with Endo H to remove N-glycan chains, while for Mid2 a mutant variant (Mid2-
N35A) was analyzed, in which the single N-glycan chain at asparagine residue 35 was deleted 
by substitution of asparagine to alanine. As can be seen in Figure 4, O-mannosylation of these 
proteins, in contrast to chitinase Cts1, was not altered in rot1-1ost3∆ cells. The faster mobility 
of Gas1 in Figure 4 (compare lanes 1 and 3) was due to a defect in N-glycosylation and hence 
could not be observed upon treatment with Endo H (lanes 4 and 6). Similarly, the mobility 
shift of Mid2-HA in rot1-1ost3∆ (lanes 7 and 8), was not the result of defective O-
mannosylation, but rather was due to the lack of N-glycosylation, as the Mid2-(N35A)-HA 
mutant variant, lacking the N-glycosylation site, had the same mobility in wild-type and rot1-
1ost3∆ cells (lanes 2 and 6). 
So far, only Cts1 showed an impairment of O-mannosylation. Since chitinase is 
exclusively mannosylated by the Pmt1-Pmt2 complex in contrast to Gas1, which is a substrate 
for the Pmt4 complex, and Ccw5 as well as Mid2, which are mannosylated by both Pmt1-
Pmt2 and Pmt4, we reasoned that only proteins modified by the Pmt1-Pmt2 complex were 
affected. Thus, a further target protein of this type, Kre9, was analyzed. However, for 
unknown reason this protein was not detectable in the rot1-1ost3∆ double mutant (Figure 4, 
lane 5), compared to wild-type or single mutant strains. It is assumed that Kre9 is degraded in 
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this genetic background, because of defective O-mannosylation. A similar observation, i.e. 
lack of detection, was also made when investigating Kre5 in rot1-2, which is another mutant 
allele of ROT1 (Takeuchi et al. 2008). 
 
Physical interaction between Rot1 and Ost3 
Previous experiments showed that Rot1 and Ost3 interact at the genetic level in a synthetic 
manner. In order to demonstrate also a physical interaction between these two proteins, a 
strain was constructed co-expressing OST3-ZZ and ROT1-HA tagged variants to perform co-
immunoprecipitation experiments. A detergent-solubilized extract from microsomal 
membranes was isolated and applied to either magnetic beads coupled with anti-HA antibody 
recognizing the HA epitope, or to an IgG-Sepharose affinity matrix recognizing the protein A 
(ZZ) epitope. After washing to remove non interacting proteins, the eluate fraction was 
analyzed for Ost3 (upper panel) and Rot1 (lower panel). As shown in Figure 6, both proteins 
co-fractionated (lanes 5 and 6) with either anti-HA-matrix or the IgG-matrix as bait for 
pulling down the HA- and ZZ-epitope, respectively. It should be mentioned that Rot1 is prone 
to aggregation and gives rise to doublet bands (lanes 5 and 6, indicated by asterisks). In 
control extracts from membranes, expressing only Rot1-HA but no Ost3-ZZ (lane 7), or 
expressing an unrelated membrane protein, Dpm1-HA (lane 8), no binding to IgG-Sepharose 
was detectable. In a further control using Sepharose (lane 9) instead of IgG-Sepharose as 
affinity-matrix, also no interaction was observed. This rules out that Rot1 and Ost3 bind in a 
non-specific manner. 
 
 
Discussion 
In this study we extend the multifunctional role of Rot1 by demonstrating that it is needed to 
ensure both proper protein N- and O-glycosylation. Rot1 is an essential ER protein that 
originally has been related to cell wall biosynthesis, actin cytoskeleton dynamics (Bickle et al. 
1998; Juanes et al. 2007; Machi et al. 2004), and more recently shown to function in protein 
folding as a molecular chaperone (Takeuchi et al. 2006a; Takeuchi et al. 2008). Rot1 does not 
have any known functional motif and the details of its molecular function have not been 
elucidated. Rot1 was shown to be transported to the ER by an SRP-independent 
posttranslational mechanism involving Sec61/Sec63 and is anchored to the ER membrane by 
a transmembrane domain at its C-terminal region (Juanes et al. 2008; Juanes et al. 2010). 
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In the first instance, a phenotypic analysis of the ROT1 mutant allele rot1-1 in combination 
with deletion of OST3, encoding a non essential subunit of OST, revealed a specific genetic 
interaction that causes temperature-dependent synthetic lethality and increased sensitivity of 
cells when stressed by drugs interfering with cell wall biogenesis (Figure 1). These 
deficiencies were not observed by deletion of its paralogue OST6. An involvement in N-
glycosylation was then further substantiated by demonstrating that in rot1-1ost3∆ cells both 
soluble and membrane-bound model N-glycoproteins were underglycosylated in vivo, and in 
accord with this finding we measured a reduced OST activity in vitro. Finally, by co-
immunoprecipitation experiments a physical interaction between Rot1 and Ost3 could be 
verified. 
OST is a multifunctional enzyme that acts at a pivotal step of the secretory pathway, at 
which protein translation and translocation into the ER, biosynthesis of lipid-linked glycosyl 
donor substrates, as well as protein glycosylation and protein folding converge. In view of the 
proposed role of Rot1 as a molecular chaperone of the ER, it is not quite unexpected that it is 
also required during glycosylation of the nascent and yet unfolded protein by assisting or 
modulating the OST complex. Thus it is conceivable that Rot1 could contribute to the 
assembly of an optimal complex, or to a better positioning of OST to the polypeptide or 
translocation site. Alternatively it could help keeping the polypeptide in a glycosylation 
competent state under certain conditions. It has been reported that the rot1-2 mutant allele 
causes activation of the UPR pathway, and ROT1 genetically interacts with KAR2 (BIP) in an 
allele specific manner suggesting cooperation in protein folding (Takeuchi et al. 2006a; 
Takeuchi et al. 2008). Kar2/BiP in yeast has been shown to be involved in various steps of 
protein maturation in the ER. It functions in protein translocation into the ER (Corsi and 
Schekman 1997), but also at later stages facilitating folding (Simons et al. 1995) and even 
contributes to ERAD (ER-associated degradation) (Fewell et al. 2001). Worth mentioning in 
this context is the finding of a genetic interaction between kar2 and wbp1 mutations, the letter 
being an essential component of OST. Interestingly, OST activity in kar2wbp1 and wbp1 
strains was the same (te Heesen and Aebi 1994) in contrast to the results obtained here with 
the rot1-1ost3∆ mutant. 
Why Ost3, but not its homolog Ost6, causes a synthetic interaction with rot1-1 is not clear 
at the moment. The identity between both proteins with 21% is rather low, but they display a 
similar membrane topology containing four transmembrane spanning domains and an ER 
luminal thioredoxin-like domain at the N-terminal region, for which a crystal structure exists 
(Schulz et al. 2009). Apart from that no primary structural differences or motifs can be 
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assigned to Ost3/Ost6 that would allow predicting sites for interaction with Rot1. Ost3 and 
Ost6 are accessory subunits of two isoforms of the OST complex and contribute to the 
specificity and efficiency at the level of individual glycosylation sites (Schwarz et al. 2005; 
Spirig et al. 2005). Ost3/Ost6 function by transiently binding stretches of the nascent substrate 
to inhibit protein folding and thus increasing glycosylation efficiency of nearby Asn residues 
(Jamaluddin et al. 2011; Schulz et al. 2009). Polypeptide binding to Ost3/Ost6 is thought to be 
transient and by mixed disulfide bonds. This is mediated by their ER luminal thioredoxin-like 
domain causing a structural change in the oxidized form and thus forming a groove 
complementary to the characteristic of the acceptor peptide stretch. Eukaryotic OST requires 
flexible domains of unfolded protein substrate, as compared to single protein OST from 
bacteria, which can also act on folded proteins (Kowarik et al. 2006). From an evolutionary 
point of view, Ost3/Ost6 are the most recent added subunits of OST (Kelleher and Gilmore 
2006) and the physically most peripheral ones (Kelleher et al. 2003). They are also thought to 
couple OST to the translocation machinery to associate with different translocons (Yan and 
Lennarz 2005a). But this has been challenged, by recent findings that Ost3 and Ost6 had 
essentially complementary functions (Schulz and Aebi 2009). 
We also observed a decrease of cis-prenyltransferase activity in rot1-1ost3∆ cells, a key 
enzyme in early steps of the glycosylation pathway, encoded by RER2. It provides dolichol 
needed for the formation of glycosyl donor substrates. This deficiency, however, may be 
different from the effect of Rot1 on OST activity. We hypothesize that this could be the result 
of an indirect effect of loss of Rot1 function by down-regulating glycosyl donor formation 
due to defective glycosylation and/or due to poorly folding. Whether the amount of the Dol-P 
precursor is indeed reduced has not been demonstrated in this study, but it has been reported 
that over-expression of RER2 in sec59-1, having a defect in dolichol kinase, is able to 
improve glycosylation. (Orlowski et al. 2007). Hence, activity of Rer2 is indeed able to affect 
the glycosylation process. Alternatively Rot1 or Rot1/Ost3 could also play a direct, 
presumably protective function for Rer2. Interestingly, in a genome wide transcriptional 
profiling in Candia albicans the transcript level of CaROT1 increased by shutting of CaRER2 
(Juchimiuk et al., in preparation). Finally, also an indirect influence by the lack of O-
mannosylation cannot be ruled out for the decrease of Rer2 activity as Dol-P plays also a role 
in this process as glycosyl donor substrate. 
Our study further revealed for the first time an involvement of Rot1 in O-mannosylation at 
least for some O-glycoproteins. Protein O-mannosylation in yeast is initiated in the ER by the 
transfer of mannose from Man-P-Dol to serine and threonine residues during translocation of 
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the secretory protein into the ER (Ruiz-Herrera and Sentandreu 1975), albeit it is possible in 
some cases that O-mannosylation can occur after the protein has entered the ER (Harty et al. 
2001). Considering the role of Rot1 as a general chaperone and the fact that N- and O-
glycosylation can compete for the same protein and therefore must be tightly coordinated, it is 
not too astonishing that Rot1 is also engaged in O-mannosylation, while the target protein is 
still in its unfolded state. A loss of Rot1 may then cause hypo-mannosylation under specific 
conditions and situations. Evidence has been presented that O-mannosylation might play a 
general role in the solubilisation of proteins in the ER and defective O-mannosylation can 
result in induction of unfolded protein response (Arroyo et al. 2011; Murakami-Sekimata et 
al. 2009; Nakatsukasa et al. 2004; Travers et al. 2000) similar to defects in N-glycosylation. 
Among the several O-glycoproteins tested, so far only Cts1 could be identified to be 
subject to Rot1 deficiency as well as Kre9, which, however, was not detectable in the rot1-
1ost3∆ background compared to wild-type and single mutants, presumably due to degradation 
as result of defective O-mannosylation. Why the other O-mannoproteins analyzed were not 
affected, can be only a matter of speculation. As mentioned above, O-mannosylation is 
catalyzed by the evolutionarily conserved PMT family classified into PMT1 (comprising 
Pmt1/5 isoforms), PMT2 (comprising Pmt2/3/6 isoforms) and PMT4 (Pmt4) subfamilies. 
They form distinct heteromeric (Pmt1-Pmt2) and homomeric (Pmt4-Pmt4) complexes, which 
in yeast are responsible for the vast majority of mannosyltransferase activity. They exhibit 
different target site specificities (Hutzler et al. 2007; Lommel and Strahl 2009), the signatures 
of which are largely elusive and remain to be determined. Merely for Pmt4 protein O-
mannosyltransferases membrane association was found to be a determinant for substrate 
recognition (Hutzler et al. 2007). Cts1, a soluble and secreted glycoprotein is known to be 
substrate exclusively for Pmt1-Pmt2, whereas Gas1 is a target for Pmt4-Pmt4, or in the case 
of Mid2 and Ccw5 both complexes contribute to glycosylation. Furthermore, it is conceivable 
that due to a compensatory cooperation other PMT-complexes may contribute to ensure O-
mannosylation. Thus, it was reported earlier that under certain physiological conditions Pmt1 
can also interact with Pmt3, and Pmt5 with Pmt2 (Girrbach and Strahl 2003). Finally, as 
Gas1, Mid2 and Ccw5 are membrane-bound and anchoring increases residence time in the 
ER, Pmt4-Pmt4 mediated O-mannosylation may have a different kinetics of the 
mannosyltransfer and is more efficient, perhaps in addition in a posttranslational manner. In 
this context it is worth mentioning that several mutant secretory proteins that are unable to 
fold properly are O-mannosylated by Pmt1 and/or Pmt2, whereas their wild-type counterparts 
are not (Coughlan et al. 2004). 
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Rot1 homologues have been identified so far only in fungi. However, proteins with similar 
function may also occur in the ER of higher eukaryotes, because of the evolutionary 
conservation of the N- and O-glycosylation as well as of the protein folding pathway. A 
genome-wide screening for Rot1 substrates and further investigation of the role of Rot1 in the 
mentioned processes will eventually lead to a better understanding of this multifunctional 
protein. 
 
Material and methods 
Strains, plasmids and media 
Yeast strains used are listed in Table 1. Strains were grown in YPD medium (1% yeast 
extract, 2% bacto-peptone, 2% glucose) or in selective YNBD medium (0.67% YNB, 0.5% 
casamino acids, 2% glucose) supplemented with amino acids and nucleotide bases, as 
required. 
To construct the expression plasmids pVT100-(TRP1)-Rot1-ZZ and pVT100-(URA3)-
Rot1-HA, genomic ROT1 was amplified from W303-1A by PCR and engineered for cloning 
purpose with Hind III and BamH I restriction sites at the 5’ and 3’ ends, respectively, and 
ligated into the Hind III / BamH I cut vectors pVT100-(TRP1)-ZZ and pVT100-(URA3)-HA, 
respectively, placing ROT1 under the control of the constitutive ADH1 promoter. The 
constructs were sequenced and the functional expression of Rot1 containing the Protein A 
(ZZ) epitope or the HA-epitope in frame at the C-terminus were verified by immunoblotting 
and complementation of the ts growth phenotype of the rot1-1rot2-1 mutant. For PCR 
amplification of ROT1 the following primers were used: ROT1 fw (5'-AGCGGCCGCATGA 
ATTGGCTGTTTTTGGTCTCGC-3') and ROT1 rev (5’-AGCGGCCGCTTATTTGAATGGT 
GCCGATAACCTT AGTAAAGC-3’). 
Chromosomal deletions of OST3 and OST6 were performed using gene specific PCR 
primers and the pFA6a-natMX6 cassette as template (Goldstein and McCusker 1999). PCR- 
products were transformed into rot1-1. Homologous integration resulted in the deletion of 
nucleotides 60–992 from the 1053-nucleotide ORF of OST3, and deletion of nucleotides 60-
935 from the 999-nucleotide ORF of OST6. Successful deletions of genes were confirmed by 
PCR using 11genomic DNA obtained from nourseothricin resistant transformants. Deletion 
primers will be provided on request. 
For monitoring the glycosylation status the following plasmids expressing C-terminal HA-
tagged versions of the respective genes were used: pVT100-Kre9-HA, YEp352-Mid2-HA, 
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YEp352-Mid2-HA(N35A) and YEp352-Ccw5-HA. Transformation into yeast was carried out 
using standard techniques. 
 
Phenotype analysis of rot1∆ cells 
Analysis of drug or temperature sensitivity of different strains was performed on YEPD plates 
in the presence of the various drugs at 25°C, or for temperature sensitivity at 37°C, 
respectively, as specified. 3 µL of serial 10-fold dilutions from a liquid culture of mid-
logarithmic phase were spotted on agar plates, starting at 3x104 cells and incubated for 72 h. 
 
Biochemical methods 
Enzyme assays. Membrane isolation and determination of oligosaccharyltransferase activity 
was performed as described (Sharma et al. 1981; Zufferey et al. 1995). OST activity was 
determined according to (Sharma et al. 1981). Determination of PMT activity was carried out 
according to (Strahl-Bolsinger and Tanner 1991). Cis-prenyltransferase activity was tested as 
published in (Szkopinska et al. 1997). 
Immunoaffinity chromatography. To verify physical interaction between Rot1 and Ost3, yeast 
membranes were collected by centrifugation, and the membrane pellet was resuspended in 30 
mM Tris-HCl pH 7.5, 3 mM MgCl2, 1 mM DTT, 3% glycerol and adjusted to 100 L of final 
volume containing 1% octylglucoside (OG), 0.5 M KCl, 20 mM Tris-Cl, pH 7.4, and 1 mg of 
membrane protein. After incubation on ice for 25 min, the mixture was centrifuged for 40 min 
at 120,000 x g, and the supernatant was applied for immunoprecipitation. Two different 
affinity media for were used. (i) IgG-Sepharose 6 (GE Healthcare) was equilibrated with 
15 mM Tris-HCl, pH 7.5, 1.5 mM MgCl2, 150 mM NaCl, and 17.5% glycerol and incubated 
with solubilized membrane extract for 1 h at 4°C with gentle shaking. Sepharose beads were 
centrifuged and washed 5 times to remove unbound material with 2 vol. of buffer containing 
1.5 mM Tris-HCl, pH 7.5, 150 mM NaCl, 15 mM MgCl2, 0.1% OG, and 17.5% glycerol. 
Elution was carried out with 100 mM glycine-HCl buffer, pH 3.3, and fractions of 0.4 mL 
were collected and analyzed by Western blot using antibodies against the ZZ- or HA-epitopes. 
(ii) As a further affinity material Dynabeads-Protein A (Invitrogen) coupled with anti-HA 
antibody was applied. Binding and elution was performed following manufacturer’s 
instructions. Dynabeads-Protein A was coupled with 5 g of anti-HA antibody in 200 L of 
antibody binding buffer and incubated under rotation for 10 min at room temperature. After 
washing four times with washing buffer, beads were incubated with membrane extract for 
20 min at room temperature followed again by washing four times with washing buffer. 
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Dissociation of the complex was carried out by adding 20 L of elution buffer and analyzed 
by Western blotting using antibodies against the ZZ- or HA-epitopes. 
 
Western blot analysis. Following SDS-PAGE, proteins were blotted to nitrocellulose, blocked 
with 5% non-fat milk and decorated with specific antibodies. CPY was analyzed from a total 
cell lysate obtained by breakage with glass beads and removal of membranes by 
centrifugation at 48,000 x g. The membrane fraction was used for immunodetection of Mid2-
HA, Mid2-(N32A)-HA and diaminopeptidase B (DPAP B). Chitinase isolated from cell walls 
was detected according to (Immervoll et al. 1995; Kuranda and Robbins 1991). Analysis of 
Ccw5, released from cell walls by 30 mM NaOH overnight at 4°C, was carried out according 
to (Mrsa et al. 1997). 
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Figure legends 
 
Fig. 1. Synthetic genetic interaction of ROT1 and OST3 
Analysis of cell growth in dependency of drugs and temperature. 3 µL of a serial 1:10 dilution 
of the indicated strains grown in liquid medium were plated on YEPD plates containing no 
additions, 5 µg/mL Calcofluor White, 5 mM caffeine, and 15 µg/mL Congo Red or 20 µg/mL 
hygromycine B starting with 3x104 cells (left). Plates were incubated for 72 h at 25°C in the 
case of drug treatment, or at 37°C for the analysis of temperature sensitivity. 
 
Fig. 2. Rot1 is required for N-glycosylation in vivo 
Analysis of glycosylation status of CPY, DPAP B, Mid2-HA and Gas1 was analyzed by 
Western blot. CPY was probed with monoclonal anti-CPY antiserum. The positions of the 
mature form of CPY (mCPY) and of the underglycosylated forms, lacking one to three 
oligosaccharide chains, are indicated. Samples of 100 µg protein were loaded for DPAP B and 
Gas1 and were detected with anti-Gas1 or anti-DPAP B antisera. 20 µg were applied for 
Mid2-HA glycosylation analysis; membranes were probed with anti-HA antibody. 
150 µg of protein was analyzed for CPY with anti-CPY antiserum. 
 
Fig. 3. Determination of OST and cis-prenyltransferase activity in vitro 
(A) OST activity was determined by measuring the transfer of radiolabeled [14C]chitobiose 
from Dol-PP-[14C]GlcNAc2 as glycosyldonor to the synthetic hexapeptide YNLTSV. (B) Cis-
prenyltransferase activity was measured in presence of radiolabeled [14C]FPP. The reaction 
products were analyzed by RP18 HPTLC and quantified by liquid scintillation counting. 
Microsomal membranes served as enzyme source. The data shown are the average of three 
independent experiments. 
 
Fig. 4. Rot1 affects O-mannosylation in vivo 
Analysis of O-mannosylation of Cts1, Ccw5-HA, Kre9-HA, Gas1 and Mid2-HA. HA-
epitope-tagged Ccw5 was extracted and analyzed from cell wall fraction. Endo H treatment 
was used to distinguish between N- and O-mannosylation of Gas1. In presence of Endo H the 
O-mannosylation status can be diagnosed. The Mid2-(N32A) mutant lacks the N-
glycosylation site allowing to exclusively analyze O-mannosylation of the protein. Blots were 
probed in the case of Cts1 and Gas1 with protein specific antibodies, or otherwise with anti-
HA specific antibody. 
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Fig. 5. Determination of Pmt activity in vitro 
Pmt activity of microsomal membranes from different strains, as specified, was measured as 
indicated in Material and methods. 
 
Fig. 6. Physical interaction of Rot1 and Ost3 
A detergent solubilized membrane extract from cells expressing OST3-ZZ and ROT1-HA was 
applied to magnetic beads coupled with antiHA (lanes 1-5) or IgG-Sepharose (lanes 6-8), and, 
as a control, on Sepharose matrix without coupled IgG (lane 9). Membrane fraction (lane 1), 
solubilized membrane extract (lane 2), washing fractions (lanes 3 and 4), and eluate fractions 
(lanes 5-9) were analyzed by Western blot with anti-IgG- (for Ost3-ZZ) and anti-HA- (for 
Rot1-HA) antibodies, respectively. As further controls, to rule out that Rot1-HA binds non-
specifically to IgG-Sepharose, extracts expressing only Rot1-HA (lane 7) or Dpm1-HA( lane 
8), but no Ost3-ZZ, were analyzed. Rot1 is subject to aggregation and prone to form doublet 
bands, as indicated by asterisks. 
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Table I. Strains used in this study 
__________________________________________________________________________________________ 
Strain   Genotype      Source 
__________________________________________________________________________________________ 
 
SS330   MATa ade2-101 ura3-52 his3∆200 tyr1   Vijayraghavan et al. 1998 
W303-1A  MATa leu2-3 leu2-112 his3-11 his3-15 ura3-1 ade2-1 trp1-1 Euroscarf 
MH272-1da  MATa leu2-3,112 ura3-52 trp1 his3::HIS4   Bickle et al. 1998 
MB134-1a  MH272-1da rot1-1      Bickle et al. 1998 
rot1-1ost3  MH134-1a ost3::natMX6     This work 
rot1-1ost6  MH134-1a ost6::natMX6      This work 
ost3   MH272-1da ost3::natMX6      This work 
ost6   MH272-1da ost6::natMX6      This work 
OST3ZZ ROT1HA  MH272-1da pVT100-(TRP1)-OST3ZZ ;pVT100-(URA3)-ROT1HA This work 
____________________________________________________________________________________________________ 
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